Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Update

Awakn Life Sciences Corp. (OTCMKTS:AWKNFGet Rating) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 900 shares, a decrease of 30.8% from the March 15th total of 1,300 shares. Based on an average daily trading volume, of 6,900 shares, the short-interest ratio is presently 0.1 days.

Shares of OTCMKTS:AWKNF opened at $1.23 on Friday. Awakn Life Sciences has a 52 week low of $0.96 and a 52 week high of $2.71. The firm has a 50-day moving average price of $1.36.

Separately, Stifel Nicolaus began coverage on shares of Awakn Life Sciences in a research note on Friday, April 1st. They set a “buy” rating for the company.

Awakn Life Sciences Company Profile (Get Rating)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Vancouver, Canada.

Read More

Receive News & Ratings for Awakn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Awakn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.